Un estudiomostró que se puede frenar el párkinson con lixisenatida
El ensayo duró solo un año y no es concluyente, [...]
A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says
Results of a large clinical trial found the treatment did [...]
An Ozempic Relative Slowed Parkinson’s Disease in a Small Study
The trial lasted only one year but offered embers of [...]
Lo que hay que saber sobre la ibogaína
Algunos investigadores esperan que la droga, aún ilegal en Estados [...]
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
Leaders of the treatment’s manufacturer, Amylyx, said they would announce [...]
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to [...]
What to Know About Ibogaine, a Psychedelic
Some researchers hope the drug, still illegal in the United [...]
R.S.V. Vaccines May Slightly Increase Risk of Rare Neurological Condition
Federal health officials presented data hinting at a link to [...]
What to Know About Xolair and Food Allergies
The drug does not completely prevent reactions, but it can [...]
Drug Drastically Reduces Children’s Reactions to Traces of Food Allergens
Xolair cuts the risk of dangerous reactions after exposure to [...]